Review
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion.
Noronha KJ, Lucas KN, Paradkar S, Edmonds J, Friedman S et al.
ReviewMolecular cancer research : MCR2024
Research Facts
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion.
Noronha KJ, Lucas KN, Paradkar S, Edmonds J, Friedman S et al.
Review ยท Moderate ยท 2024
Findings

PubMed study on Di-C12-15 Alkyl Fumarate in cosmetics/dermatology

Design
Review
Evidence
Moderate
Journal
Molecular cancer research : MCR